HOME › DRUGS › EPTACOG ALFA (ACTIVATED)
ACTIVE SUBSTANCE / INN

EPTACOG ALFA (ACTIVATED)

Brand name(s): HemAryo, NovoSeven
EMA LISTED
APPLICATION WITHDRAWN
AUTHORISED
Hemophilia A;Hemophilia B;Factor VII Deficiency
Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia…
ACTIVE SUBSTANCE
Eptacog Alfa (Activated)
REGULATORS
EMA
SPONSORS / MAH
Novo Nordisk A/S, UGA Biopharma
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NovoSevenNovo Nordisk A/SAuthorised23/02/1996Hemophilia B;Thrombasthenia;Factor VII Deficiency;Hemophilia A
HemAryoUGA BiopharmaApplication withdrawnHemophilia A;Hemophilia B;Factor VII Deficiency

FULL INTELLIGENCE ON EPTACOG ALFA (ACTIVATED)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →